Discover the value of Spatial Biology by winning a Whole Transcriptome Atlas grant to spatially profile your tissue of interest
NanoString & Citogen will award the most impactful proposal in any field of research aiming to study tissue heterogeneity and discover spatial biomarkers by spatial transcriptomics. The winner of the Whole Transcriptome Atlas grant will be able to spatially quantify gene expression in your regions of interest using the full coverage of protein coding genes provided by GeoMx Whole Transcriptome Atlas (WTA) in a GeoMx® Digital Spatial Profiler platform.

All researchers across Spain and Portugal are invited to submit their abstracts to spatially profile their tissue of interest either from:


Spatial transcriptomics uncovered by the WTA will unlock the possibility to explore new pathways and biomarkers that can be applied in oncology, immunology, neuroscience, developmental biology, or any field of research.


Whether you are a basic or translational researcher, the NanoString GeoMx® Digital Spatial Profiler is the most flexible spatial solution combining standard immunofluorescence techniques with digital optical barcoding technology to perform highly multiplexed, spatially-resolved profiling experiments.


Apply in English or in Spanish from now until September 14th.
Grant Details

  • The grant is open to all researchers from Spain and Portugal from all fields of research.
  • NanoString will award a GeoMx® Whole Transcriptome Atlas (WTA) to the most impactful proposal with the purpose to discover spatial biomarkers, study tissue heterogeneity or cell-type specific questions by spatial gene expression profiling.
  • Comprehensive, unbiased RNA content for human and mouse: Explore any target and any pathway in your biological regions of interest with full flexibility. The GeoMx Whole Transcriptome Atlas (WTA) provides an unbiased view of 18,000+ (Human) or 21,0000+ (Mouse) protein-coding genes.
  • Sample types: FFPE, OCT embedded and Fresh Frozen.
  • NanoString standard morphology markers  or H&E staining: Fluorescently-labeled morphology markers are used for the visualization of tissue morphology, the selection of regions of interest (ROI), and the segmentation of ROIs into distinct biological compartments, or areas of interest (AOI). The winner will receive 2 slides and 22 areas of illumination (AOI) for the GeoMx WTA Assay. The experiment will be run at Citogen facilities.
  • Data analysis support: The GeoMx DSP data center provides an end-to-end software solution from image acquisition and region of interest selection to a fully integrated data analysis experience. Quality Control, Data normalization and Basic statistical analysis between the 2 conditions/slides included in the award. NanoString experts will show the awardees how to use the GeoMx DSP Data Center.  
  • Applications must be submitted before 23h59 CET by September 14th 2021.




























All grant applicants agree that NanoString may process the personal data he or she provides as part of application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies.


By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, for marketing purposes.

Terms and Conditions

Publication of Project Results:
All grant submissions are confidential to the individual submitter and will not be published or distributed, provided, however, that NanoString & Citogen& may share them with their own staff and distributors who will not disclose to third party. Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString & Citogen and winner: webinar, case study, blog post, or poster presentation. The winner agrees that NanoString and Citogen shall have the right to publicly announce the winner’s name and research topic and use anonymized data from the winner's project in application notes including in marketing materials and seminars.

Eligibility and Requirements:
Applicants must be actively enrolled or employed at an institution or company in Spain or Portugal in a capacity in which they perform life science research and have the ability to ship and analyze samples within 45 days of award notification.  The winner must be age 18 or older.  Members of the immediate families of NanoString or Citogen employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. The grant winner's samples will be run with 2 slides, with up to 22 Areas of Illumination (AOI) in total  to be mutually agreed upon, to be used with the GeoMx® Whole Transcriptome Atlas Assay run through Citogen.  NanoString standard morphology markers or H&E staining will be used for Region of Interest (ROI) selection. NanoString experts will show the winners how to use the GeoMx DSP Data Center.  The winner will receive data analysis with a white glove approach that covers: Quality Control, Data normalization and Basic statistical analysis between 2 conditions.

Miscellaneous:
By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, for marketing purposes. All grant applicants agree that NanoString and Citogen may process the personal data he or she provides as part of application, including sharing such data with NanoString and Citogen’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at www.nanostring.com/privacy

The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString.  No substitution or transfer of the awarded grant is allowed, except as otherwise permitted by NanoString.  The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award.  If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program.  NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose.  This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence.  All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum.  By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.


For Research Use Only. Not for use in diagnostic procedures.